Cargando…
Editing the genome of hiPSC with CRISPR/Cas9: disease models
The advent of human-induced pluripotent stem cell (hiPSC) technology has provided a unique opportunity to establish cellular models of disease from individual patients, and to study the effects of the underlying genetic aberrations upon multiple different cell types, many of which would not normally...
Autor principal: | Bassett, Andrew R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569153/ https://www.ncbi.nlm.nih.gov/pubmed/28303292 http://dx.doi.org/10.1007/s00335-017-9684-9 |
Ejemplares similares
-
Rapid target validation in a Cas9-inducible hiPSC derived kidney model
por: Shamshirgaran, Yasaman, et al.
Publicado: (2021) -
α-synuclein pathogenesis in hiPSC models of Parkinson’s disease
por: Baena-Montes, Jara M., et al.
Publicado: (2021) -
A mathematical model of hiPSC cardiomyocytes electromechanics
por: Forouzandehmehr, Mohamadamin, et al.
Publicado: (2021) -
Emerging hiPSC Models for Drug Discovery in Neurodegenerative Diseases
por: Trudler, Dorit, et al.
Publicado: (2021) -
hiPSC-Derived Cells as Models for Drug Discovery
por: Ofir, Rivka
Publicado: (2021)